Atomwise, Inc.

In 2023, China was the second largest product/technology exporter in the global biopharmaceutical pipeline, with 143 pipeline transactions, runner up only to the US. In China’s biopharmaceutical indus

Alliances centered on artificial intelligence and machine learning (AI/ML) applications have become ubiquitous in the biopharmaceutical sector in recent years and are projected to accelerate. But a re

These are still heady days for the newly in-power Labour party, not yet passed the 100-day honeymoon period and not yet the target of too much criticism, which, history tells us, will not be too far a

“The power of AI isn’t about making drugs faster,” said Abraham Heifets, CEO of Atomwise, Inc. , an AI-enabled drug discovery company headquartered in San Francisco. “If you approach a big pharma and